Report for: Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review

Title	Safety and Efficacy of Co-Trimoxazole for Treatment and Prevention of Plasmodium falciparum Malaria: A Systematic Review
Published in	PLOS ONE, February 2013
DOI	10.1371/journal.pone.0056916
Pubmed ID	23451110
Authors	Christine Manyando, Eric M. Njunju, Umberto D’Alessandro, Jean-Pierre Van geertruyden
Abstract	Cotrimoxazole (CTX) has been used for half a century. It is inexpensive hence the reason for its almost universal availability and wide clinical spectrum of use. In the last decade, CTX was used for prophylaxis of opportunistic infections in HIV infected people. It also had an impact on the malaria risk in this specific group.

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.

Country	Count	As %
United States	1	50%
Unknown	1	50%

Type	Count	As %
Members of the public	2	100%

Mendeley readers

The data shown below were compiled from readership statistics for 150 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Readers by professional status	Count	As %
Student > Master	26	17%
Researcher	17	11%
Student > Ph. D. Student	17	11%
Student > Postgraduate	15	10%
Student > Bachelor	11	7%
Other	40	27%
Unknown	24	16%

Readers by discipline	Count	As %
Medicine and Dentistry	48	32%
Agricultural and Biological Sciences	21	14%
Immunology and Microbiology	10	7%
Nursing and Health Professions	9	6%
Pharmacology, Toxicology and Pharmaceutical Science	9	6%
Other	27	18%
Unknown	26	17%

PLOS